HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 58, Number 8, April 23, 2002 Correction (v58,p1444) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuhlenbäumer, G. Articles by Stögbauer, F. Search for Related Content PubMed PubMed Citation Articles by Kuhlenbäumer, G. Articles by Stögbauer, F. Related Collections Peripheral neuropathy All Genetics

Giant axonal neuropathy (GAN): Case report and two novel mutations in the gigaxonin gene

*Authors contributed equally to this article.
From the Department of Neurology (Drs. Kuhlenbäumer, Young, Hünermund, Ringelstein, and Stögbauer, and A. Schirmacher), and Department of Psychiatry (K. Domschke), University of Münster; and Department of Neurology (Dr. Oberwittler), St. Vincenz Krankenhaus, Limburg, Germany.

Address correspondence and reprint requests to F. Stögbauer, MD, Department of Neurology, University of Münster, Albert Schweitzer Str. 33, 48129 Münster, Germany; e-mail: stogbau{at}uni-muenster.de

Giant axonal neuropathy (GAN) is an autosomal recessive neurologic disorder clinically characterized by a severe polyneuropathy, CNS abnormalities, and characteristic tightly curled hair. Recently, mutations in the gigaxonin gene have been identified as the underlying genetic defect. The authors report two novel mutations confirming that GAN is caused by mutations in the gigaxonin gene and raise the question whether some mutations may cause a mild subclinical neuropathy.

This article has been cited by other articles:

				D. W. Cleveland, K. Yamanaka, and P. Bomont Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway Hum. Mol. Genet., April 15, 2009; 18(8): 1384 - 1394. [Abstract] [Full Text] [PDF]

				H. Houlden, M. Groves, Z. Miedzybrodzka, H. Roper, T. Willis, J. Winer, G. Cole, and M. M Reilly New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1267 - 1270. [Abstract] [Full Text] [PDF]

				J. Ding, E. Allen, W. Wang, A. Valle, C. Wu, T. Nardine, B. Cui, J. Yi, A. Taylor, N. L. Jeon, et al. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport Hum. Mol. Genet., May 1, 2006; 15(9): 1451 - 1463. [Abstract] [Full Text] [PDF]

				E Demir, P Bomont, S Erdem, L Cavalier, M Demirci, G Kose, S Muftuoglu, A N Cakar, E Tan, S Aysun, et al. Giant axonal neuropathy: clinical and genetic study in six cases J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 825 - 832. [Abstract] [Full Text] [PDF]

				X. Li, D. Zhang, M. Hannink, and L. J. Beamer Crystal Structure of the Kelch Domain of Human Keap1 J. Biol. Chem., December 24, 2004; 279(52): 54750 - 54758. [Abstract] [Full Text] [PDF]

				C. Bruno, E. Bertini, A. Federico, E. Tonoli, M. L. Lispi, D. Cassandrini, M. Pedemonte, F. M. Santorelli, M. Filocamo, M. T. Dotti, et al. Clinical and molecular findings in patients with giant axonal neuropathy (GAN) Neurology, January 13, 2004; 62(1): 13 - 16. [Abstract] [Full Text] [PDF]

				D. N. Herrmann and J. W. Griffin Intermediate filaments: A common thread in neuromuscular disorders Neurology, April 23, 2002; 58(8): 1141 - 1143. [Full Text] [PDF]